Arthur E. Frankel
Affiliations: | Wake Forest University, Winston-Salem, NC, United States | ||
| 2013- | University of Texas Southwestern Medical Center, Dallas, TX, United States |
Area:
Oncology, Biochemistry, Molecular BiologyWebsite:
http://profiles.utsouthwestern.edu/profile/138072/arthur-frankel-biography.htmlGoogle:
"Arthur Frankel"Bio:
http://www.pnas.org/content/73/10/3705.short
http://jvi.asm.org/content/21/1/153.short
Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Brenner A, Falchook G, Patel M, et al. (2017) Abstract P6-11-09: Heavily pre-treated breast cancer patients show promising responses in the first in human study of the first-In-class fatty acid synthase (FASN) inhibitor, TVB-2640 in combination with paclitaxel Cancer Research. 77 |
| Bekdash A, Darwish M, Timsah Z, et al. (2015) Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF). Translational Oncology. 8: 347-57 |
| Khoury O, Ghazale N, Stone E, et al. (2015) Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. Journal of Neuro-Oncology. 122: 75-85 |
| Angelot-Delettre F, Roggy A, Frankel AE, et al. (2015) In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent. Haematologica. 100: 223-30 |
| Frolova O, Benito J, Brooks C, et al. (2014) SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia. British Journal of Haematology. 166: 862-74 |
| Tanios R, Bekdash A, Kassab E, et al. (2013) Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells. Leukemia Research. 37: 1565-71 |
| Kassab E, Darwish M, Timsah Z, et al. (2013) Cytotoxicity of anthrax lethal toxin to human acute myeloid leukemia cells is nonapoptotic and dependent on extracellular signal-regulated kinase 1/2 activity. Translational Oncology. 6: 25-32 |
| Yang X, Kessler E, Su LJ, et al. (2013) Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 148-57 |
| Agrawal V, Woo JH, Mauldin JP, et al. (2012) Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells. Anti-Cancer Drugs. 23: 51-64 |
| Flaig TW, Su L, Thorburn A, et al. (2011) DAB389 EGF for the treatment of superficial urothelial cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 255 |